BioNTech eyes COVID vaccine for 12-15 year olds from June in EU
BioNTech said Thursday that it expected its COVID-19 vaccine, jointly developed with Pfizer, to be available to 12-to-15-year-olds in Europe from June.
by ·
BioNTech said Thursday that it expected its COVID-19 vaccine, jointly developed with Pfizer, to be available to 12-to-15-year-olds in Europe from June.
by · Published June 7, 2021
by · Published April 26, 2021
by · Published May 21, 2021